L-Lysine,N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-,hydrochloride (9CI) (98930-70-2)

Identification
Name:	L-Lysine,N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-,hydrochloride (9CI)
Synonyms:	1H-Thieno[3,4-d]imidazole,L-lysine deriv.; Biocytin hydrochloride
CAS:	98930-70-2
Molecular Formula:	C16H28 N4 O4 S . x Cl H
Molecular Weight:	408.94
Molecular Structure:
Properties
Storage Temperature:	−20°C
Safety Data

Other Product

Vasopressin,1-(3-mercaptopropanoicacid)-8-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
Substance P,3-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
L-Lysine,N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-,hydrazide
Glucagon (swine),N-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-12-[N6-(1-iminoethyl)-L-lysine]-,monohydrochloride, [3aS-(3aa,4b,6aa)]- (9CI)
Neuropeptide Y (swine),7-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
L-Lysine,N6-[6-[[5-[(3aS,4S,6aR)-hexahydro- 2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1- oxopentyl]amino]-1-oxohexyl]-
L-Lysine,N2-[(1,1-dimethylethoxy)carbonyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
w-Conotoxin G VIA,2-[N6-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
L-Lysine,N2-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
L-Lysine,1,1'-[[(carboxymethyl)imino]di-2,1-ethanediyl]bis[N-(carboxymethyl)glycyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-(9CI)
D-Lysine,N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
L-Lysine,N2,N2-bis(carboxymethyl)-N6-[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]-,potassium salt (1:3)
L-Lysine,N2-[4-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxobutyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
L-Lysinamide,N-acetyl-L-tyrosyl-L-valyl-N-[(1S)-1-(carboxymethyl)-3-[(2,6-dimethylbenzoyl)oxy]-2-oxopropyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-(9CI)
L-Proline,1-[N2-(1-carboxy-3-phenylpropyl)-N6-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-L-lysyl]-,[3aS-[3aa,4b(R*),6aa]]- (9CI)
L-Proline,1-[N2-(1-carboxy-3-phenylpropyl)-N6-[N-[N-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-b-alanyl]-b-alanyl]-L-lysyl]-, [3aS-[3aa,4b(R*),6aa]]- (9CI)
Substance P,1-de-L-arginine-2-de-L-proline-3-[N2-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
Dynorphin A (swine),13-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysinamide]-14-de-L-tryptophan-15-de-L-asparticacid-16-de-L-asparagine-17-de-L-glutamine-, [3aS-(3aa,4b,6aa)]- (9CI)
L-Lysinamide,N-[[(2S,3S)-3-(ethoxycarbonyl)-2-oxiranyl]carbonyl]-L-leucyl-L-tyrosyl-6-aminohexanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
L-Lysinamide,N-[(7-amino-4-methyl-2-oxo-2H-1-benzopyran-3-yl)acetyl]-L-a-glutamyl-L-a-glutamyl-L-lysyl-L-prolyl-L-isoleucyl-L-seryl-L-phenylalanyl-L-phenylalanyl-L-arginyl-L-leucylglycyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-(9CI)